Paladin terminates its unsolicited offer to acquire the 85.1% of Afexa it does not already own

Afexa Life Sciences Inc.

Canada / Other

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Paladin Labs Inc.

Canada / Small-Cap Biopharma (<$1 billion)

$841.6m on 08/12/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Canceled

Sample

01/01/2009

announced

01/01/2009

Canceled